Spectrum Pharmaceuticals Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 86

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 14

  • Investments
  • 8

Spectrum Pharmaceuticals General Information

Description

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are it's current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor ("G-CSF") for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer ("NSCLC") tumors with various mutations. It has one segment that is focused exclusively on developing and marketing oncology and hematology drug products.

Contact Information

Website
www.sppirx.com
Formerly Known As
NeoTherapeutics, Americus Funding Corp., Neotherapeutics Inc
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Pilot House - Lewis Wharf, 2 Atlantic Avenue
  • 6th Floor
  • Boston, MA 02110
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Pilot House - Lewis Wharf, 2 Atlantic Avenue
  • 6th Floor
  • Boston, MA 02110
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spectrum Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Spectrum Pharmaceuticals‘s full profile, request access.

Request a free trial

Spectrum Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company w
Drug Discovery
Boston, MA
86 As of 2022

Redwood City, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spectrum Pharmaceuticals Competitors (43)

One of Spectrum Pharmaceuticals’s 43 competitors is Coherus Oncology, a Formerly VC-backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Coherus Oncology Formerly VC-backed Redwood City, CA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Nanoviricides Corporation Shelton, CT
Gilead Formerly VC-backed Foster City, CA
Moderna Formerly VC-backed Cambridge, MA
You’re viewing 5 of 43 competitors. Get the full list »

Spectrum Pharmaceuticals Patents

Spectrum Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230277628-A1 Methods for promoting anti-tumor immune response in a subject in need thereof using encapsulated interleukin 12 Inactive 04-Mar-2022
WO-2023015149-A1 Treatment of non-small cell lung cancer with poziotinib Inactive 02-Aug-2021
WO-2022147150-A1 Treatment of malignant solid tumors Inactive 29-Dec-2020
WO-2022087371-A1 Novel bicyclic compounds Inactive 22-Oct-2020
WO-2022087375-A1 Novel heterocyclic compounds Inactive 22-Oct-2020 A61K45/06
To view Spectrum Pharmaceuticals’s complete patent history, request access »

Spectrum Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spectrum Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Spectrum Pharmaceuticals‘s full profile, request access.

Request a free trial

Spectrum Pharmaceuticals Investments & Acquisitions (8)

Spectrum Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with ImmunGene (Focused Interferon Therapeutics) for . The deal was made on 09-May-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ImmunGene (Focused Interferon Therapeutics) 09-May-2019 Corporate Asset Purchase Buildings and Property
Valerio Therapeutics 13-Nov-2014 PIPE Biotechnology
Talon Therapeutics 18-Jun-2013 Merger/Acquisition Pharmaceuticals
Allos Therapeutics 05-Sep-2012 Merger/Acquisition Drug Discovery
RIT Oncology 15-Mar-2009 Merger/Acquisition Drug Discovery
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Spectrum Pharmaceuticals FAQs

  • When was Spectrum Pharmaceuticals founded?

    Spectrum Pharmaceuticals was founded in 1987.

  • Where is Spectrum Pharmaceuticals headquartered?

    Spectrum Pharmaceuticals is headquartered in Boston, MA.

  • What is the size of Spectrum Pharmaceuticals?

    Spectrum Pharmaceuticals has 86 total employees.

  • What industry is Spectrum Pharmaceuticals in?

    Spectrum Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Spectrum Pharmaceuticals a private or public company?

    Spectrum Pharmaceuticals is a Private company.

  • What is the current valuation of Spectrum Pharmaceuticals?

    The current valuation of Spectrum Pharmaceuticals is .

  • What is Spectrum Pharmaceuticals’s current revenue?

    The current revenue for Spectrum Pharmaceuticals is .

  • How much funding has Spectrum Pharmaceuticals raised over time?

    Spectrum Pharmaceuticals has raised $298M.

  • Who are Spectrum Pharmaceuticals’s investors?

    Federated Kaufmann Fund, LRG Capital, and UMS Partners have invested in Spectrum Pharmaceuticals.

  • Who are Spectrum Pharmaceuticals’s competitors?

    Coherus Oncology, Alnylam Pharmaceuticals, Nanoviricides, Gilead, and Moderna are some of the 43 competitors of Spectrum Pharmaceuticals.

  • When was Spectrum Pharmaceuticals acquired?

    Spectrum Pharmaceuticals was acquired on 31-Jul-2023.

  • Who acquired Spectrum Pharmaceuticals?

    Spectrum Pharmaceuticals was acquired by Assertio Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process